These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 20534340)

  • 1. Harnessing the antioxidant power with ARE-inducing compounds.
    Kobayashi M
    Chem Biol; 2010 May; 17(5):419-20. PubMed ID: 20534340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
    de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
    Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule microarrays: recent advances and applications.
    Uttamchandani M; Walsh DP; Yao SQ; Chang YT
    Curr Opin Chem Biol; 2005 Feb; 9(1):4-13. PubMed ID: 15701446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streamlining lead discovery by aligning in silico and high-throughput screening.
    Davies JW; Glick M; Jenkins JL
    Curr Opin Chem Biol; 2006 Aug; 10(4):343-51. PubMed ID: 16822701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of peptides in Diogenesis: a novel approach to drug discovery and phenomics.
    Blume AJ; Beasley J; Goldstein NI
    Biopolymers; 2000; 55(4):347-56. PubMed ID: 11169925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-world phenomena in chemical library networks: application to fragment-based drug discovery.
    Tanaka N; Ohno K; Niimi T; Moritomo A; Mori K; Orita M
    J Chem Inf Model; 2009 Dec; 49(12):2677-86. PubMed ID: 19961207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
    Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
    Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 as a novel molecular target for chemoprevention.
    Lee JS; Surh YJ
    Cancer Lett; 2005 Jun; 224(2):171-84. PubMed ID: 15914268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
    Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
    Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonists.
    Schepetkin IA; Kirpotina LN; Khlebnikov AI; Quinn MT
    Mol Pharmacol; 2007 Apr; 71(4):1061-74. PubMed ID: 17229869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
    Evensen L; Micklem DR; Link W; Lorens JB
    Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors.
    Kolb P; Kipouros CB; Huang D; Caflisch A
    Proteins; 2008 Oct; 73(1):11-8. PubMed ID: 18384152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule biaryl FSH receptor agonists. Part 1: Lead discovery via encoded combinatorial synthesis.
    Guo T; Adang AE; Dolle RE; Dong G; Fitzpatrick D; Geng P; Ho KK; Kultgen SG; Liu R; McDonald E; McGuinness BF; Saionz KW; Valenzano KJ; van Straten NC; Xie D; Webb ML
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1713-6. PubMed ID: 15026056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using high-throughput screening data to discriminate compounds with single-target effects from those with side effects.
    Klekota J; Brauner E; Roth FP; Schreiber SL
    J Chem Inf Model; 2006; 46(4):1549-62. PubMed ID: 16859287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making an unbiased library.
    Vinson V
    Science; 2017 Apr; 356(6334):149-151. PubMed ID: 28408584
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders.
    Gao B; Doan A; Hybertson BM
    Clin Pharmacol; 2014; 6():19-34. PubMed ID: 24520207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling environmental chemicals for activity in the antioxidant response element signaling pathway using a high throughput screening approach.
    Shukla SJ; Huang R; Simmons SO; Tice RR; Witt KL; Vanleer D; Ramabhadran R; Austin CP; Xia M
    Environ Health Perspect; 2012 Aug; 120(8):1150-6. PubMed ID: 22551509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-restricted expression of Nrf2 and its target genes in zebrafish with gene-specific variations in the induction profiles.
    Nakajima H; Nakajima-Takagi Y; Tsujita T; Akiyama S; Wakasa T; Mukaigasa K; Kaneko H; Tamaru Y; Yamamoto M; Kobayashi M
    PLoS One; 2011; 6(10):e26884. PubMed ID: 22046393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.